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A B S T R A C T
Mediterranean spotted fever (MSF) is endemic in Italy, where Rickettsia conorii subsp. conorii was thought
to be the only pathogenic rickettsia and Rhipicephalus sanguineus the vector and main reservoir. R. conorii
subsp. israelensis, which belongs to the R. conorii complex, is the agent of Israeli spotted fever (ISF); apart
from Israel, it has also been found in Italy (Sicily and Sardinia) and in different regions of Portugal. We
describe here two severe cases of ISF which occurred in otherwise healthy Italian adults. Their
characteristics are analyzed and discussed in the light of other 91 cases found through a systematic
review of international literature.
© 2017 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Rickettsia conorii subsp. israelensis, which belongs to the R.
conorii complex, is the agent of Israeli spotted fever (ISF). It was
ﬁrst reported in 1974 in Israel and distribution appeared to beAbbreviations: MSF, Mediterranean spotted fever; ISF, Israeli spotted fever; PCR,
Polymerase chain reaction; MRI, Magnetic resonance imaging; ICU, intensive care
unit; IFA, Immunoﬂuorescence assay; ELISA, enzyme-linked immunosorbent assay;
n.v., normal value; NA, not available.
* Corresponding author. Telephone +390916554054, Fax +390916554050.
E-mail addresses: claudia.colomba@libero.it (C. Colomba),
marcellotrizzino@hotmail.it (M. Trizzino), anna.giammanco@unipa.it
(A. Giammanco), celestino.bonura@unipa.it (C. Bonura), danilo.dibona@uniba.it
(D. Di Bona), mtolomeo@hotmail.com (M. Tolomeo), antonio.cascio03@unipa.it
(A. Cascio).
http://dx.doi.org/10.1016/j.ijid.2017.04.003
1201-9712/© 2017 The Authors. Published by Elsevier Ltd on behalf of International Soc
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).restricted only to that country (Goldwasser et al., 1974; Mumcuo-
glu et al., 2002).
Several cases of postmortem diagnosis of ISF have been
described in children and adults in Israel using cell culture
methods, animal inoculation and immunohistochemical detection
of rickettsial antigen in parafﬁn-embedded tissue obtained at
autopsy (Yagupsky and Wolach, 1993; Aharonowitz et al., 1999
Aharonowitz et al., 1999). Only later was nested PCR applied to sera
and tissue in several fatal cases of rickettsial infections and shown
to be effective in establishing the correct diagnosis (Schattner et al.,
1992; Keysary et al., 2007; Weinberger et al., 2008).
Rickettsia conorii subsp. conorii was thought to be the only
pathogenic rickettsia of the spotted fever group in Europe where it
is endemic in southern Europe, with sporadic cases reported in
northern and central Europe. Rhipicephalus sanguineus is the vector
and a potential reservoir of R. conorii subsp. conorii in theiety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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recognized tick-borne rickettsioses have been shown to be present
in Europe (Parola et al., 2013), and R. conorii subsp. israelensis has
also been detected in Rhipicephalus sanguineus and in human cases
in Sicily and Sardinia, Italy and in different regions of Portugal
(Giammanco et al., 2003; Chisu et al., 2014; Giammanco et al.,
2005a; Bacellar et al., 1999; Bacellar et al.,1995; Amaro et al., 2003;
De Sousa et al., 2003a; De Sousa et al., 2008; De Sousa et al., 2005).
Every year, about 300 cases of Mediterranean spotted fever
(MSF) are notiﬁed (mainly from June through September) in the
Italian island of Sicily.
MSF is typically characterized by fever, skin rash and a black
eschar at the site of the tick bite (“tache noire”) (Cascio et al., 2001;
Colomba et al., 2006 Colomba et al., 2006).
We report here two cases of ISF in otherwise healthy Sicilian
adults and review all articles describing cases of ISF in which the
diagnosis was made using molecular biology techniques.
Case 1
A 45-year-old Romanian man, in Italy for ﬁve years, previously
healthy, except for a treated pulmonary tuberculosis ten years
before, was admitted to Palermo University Hospital, Italy, in July
2016 for an history of fever (39 C), headache, mialgia and
weakness for 5 days. One day before admission a generalized
rash developed. The patient was an alcoholic and lived in a rural
environment in Sicily and owned a dog.
On admission, he was febrile (38.9 C), tachycardic (120/min),
tachypnoeic (40/min), oliguric and complained of severe muscle
pain. A physical examination showed diffuse macular rash on the
trunk and extremities, including palms and soles. The day after
admission, a few petechial lesions appeared on his legs. Laboratory
investigations yielded the following results: C-reactive protein
level 253 mg/L (n.v. <5 mg/L); leukocyte count, 5.9  109/L; platelet
counts, 13  109/L; creatinine 1.08 mg/dL; aspartate aminotrans-
ferase, 464 U/L; alanine aminotransferase, 126 U/L; g-glutamyl-
transpeptidase, 45 U/L; pH 7.45; lactate, 2.5 mmol/L; D-dimer,
19.000 ng/mL (n.v. 10–250 ng/mL). Routine blood and urine
cultures, serologic tests for HIV, Leptospira spp. and Rickettsia
spp. were performed but the results were not diagnostic.
Treatment with intravenous piperacillin-tazobactam (4.5 gr three
times a day) plus vancomicin (1 gr twice a day) and oral
doxycycline (100 mg twice a day) was immediately started.
On the second day of hospitalization, the patient’s condition
worsened: the skin rash became overtly petechial, and the picture
of severe sepsis with multiorgan system failure worsened.
Laboratory results were not diagnostic except real-time PCR assay
for R. conorii subsp. Israelensis.
Rickettsial DNA was detected from full blood specimens with a
highly sensitive real-time PCR assay for the detection of spotted
fever and typhus group rickettsiae using previously published
primers and probe to the Rickettsia rickettsii citrate synthase gene,
gltA (Stenos et al., 2005). The CSisr-P probe (50-FAM-TGT AAT AGC
AAG AAT CGT AGG CTG GAT G-TAMRA-30) was speciﬁcally designed
from a highly conserved region of the citrate synthase gene to
detect R. conorii subsp. israelensis in addition to SFG rickettsiae.
The patient was treated with doxycycline for seven days, and
fever subsided completely after three days of treatment. The
patient was discharged from hospital 10 days after admission,
without any sequel.
Case 2
A 65-year-old otherwise healthy Italian woman was hospital-
ized with a 6-day history of high fever (40 C), headache, vomiting
and, four days later, a maculopapular rash involving the trunk,limbs, palms, and soles. On admission, the patient was agitated,
confused, dysarthric and exhibited bilateral dysdiadochokinesis.
Mild neck stiffness and positive Kernig’s sign were present. She
was febrile (39 C), tachycardic (100 bpm), and tachypnoeic
(respiratory rate 28 breaths per minute). A maculopapular rash
covered the entire body surface, and petechial lesions were also
present on the ankles. A brain CT scan was negative for acute
ischemic-hemorrhagic events. MRI, performed with the suspect of
encephalitis, showed gliotic outcomes based on hypoxic-ischemic
lesions. Laboratory investigations yielded the following results: C-
reactive protein level 67 mg/L, leukocyte count 52  109/L, platelet
count 73  109/L, aspartate aminotransferase 172 U/L; alanine
aminotransferase 289 U/L, d-dimer 2264 ng/mL. Routine blood
and urine cultures, serologic tests and PCR for Rickettsia spp. were
performed. (see above). The patient did not give consent for the
execution of a lumbar puncture. Treatment with intravenous
ceftriaxone (2 g twice a day) plus vancomicin (1 g twice a day) and
oral doxycycline (100 mg twice a day) was immediately started.
Laboratory results were not diagnostic except real-time PCR assay
for R. conorii subsp. israelensis. The patient was treated with
doxycycline for seven days and was discharged from hospital
20 days after admission. Fever subsided completely after four days
of hospitalization.
Literature review and discussion
For the review of published cases, a PubMed search was
performed combining the terms (israelensis OR israeli) AND
(Rickettsia OR Rickettsioses OR Conorii) without limits; references
were also checked for relevant articles, including review papers.
A study was considered eligible for inclusion in the review if it
reported cases of ISF documented by molecular biology methods.
Our search retrieved 69 articles; of them, 30 described human
cases of probable ISF (Yagupsky and Wolach, 1993; Weinberger
et al., 2008; Giammanco et al., 2005a; Bacellar et al., 1999; Amaro
et al., 2003; De Sousa et al., 2003a; De Sousa et al., 2008; De Sousa
et al., 2005; Bota et al., 2016; Znazen et al., 2011; Boillat et al., 2008;
Chai et al., 2008; Znazen et al., 2013; Mokrani et al., 2012; Oteo and
Portillo, 2012; Atias et al., 2010; Harrus et al., 2007; Brouqui et al.,
2007; De Sousa et al., 2006; Giammanco et al., 2005b; De Sousa
et al., 2003b; Leitner et al., 2002; Klein et al., 1995; Eremeeva et al.,
1994; Kelly et al., 1994; Manor et al., 1992; Hanuka et al., 1992;
Rehácek and Tarasevich, 1991; Wolach et al., 1989; Yagupsky and
Gross, 1985) but only the 9 describing 91 patients with ISF
conﬁrmed by molecular biology techniques (Weinberger et al.,
2008; Giammanco et al., 2005a; Bacellar et al., 1999; Amaro et al.,
2003; De Sousa et al., 2008; Bota et al., 2016; Znazen et al., 2011;
Boillat et al., 2008; Chai et al., 2008) were further considered
(Figure 1).
Most of the articles were single case reports, but there was one
large case series by De Sousa et al. (De Sousa et al., 2003a; De Sousa
et al., 2008).
Data regarding the clinical characteristics, therapy, diagnosis
and outcome of the above 91 patients with ISF and our two new
cases are shown in Table 1.
All but two cases were contracted in three countries: Israel,
Portugal and Italy. One case was reported in a patient returning
from a trip to Libya and one case in Tunisia (Znazen et al., 2011;
Boillat et al., 2008). Mean age was 56.2 (min. max 12-76; sd
15.29).
Medical history was unremarkable in all reviewed cases
reported except in the ﬁrst of our two cases that had a history
of chronic alcohol abuse.
The illness had a sudden onset with fever (81%), rash (77%),
headache (44%); tache noire was present in 27% of the cases, and
gastrointestinal symptoms were present in 50% of the cases. 27.3%
Figure 1. Study selection. Algorithm depicting literature search ﬂow chart and why
studies were included or excluded.
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failure, purpura fulminans and acute encephalitis.
In all cases, molecular biology techniques allowed the detection
of copies of rickettsial DNA with ampliﬁcation of speciﬁc
sequences of the genes encoding 16S rRNA, the 17-kDa protein,
citrate synthase (gltA), and the outer membrane proteins OmpA
and OmpB (Znazen et al., 2013) on blood (13 cases), eschar (3 cases)
and autopsy samples (2 cases).
Serology, performed with immunoﬂuorescence assay (IFA) or
enzyme-linked immunosorbent assay (ELISA), was positive in only
11% of cases.
In all cases, therapeutic regimens included intravenous or oral
doxycycline.
ISF does not appear to be limited to Israel, but is more
widespread in the Mediterranean countries than ﬁrst believed, and
cases from Italy, Portugal, Libya and Tunisia have been reported.
The two cases of severe ISF we described had a favorable course.
Case 1 experienced severe sepsis reaching new criteria for
diagnosis of sepsis (Giamarellos-Bourboulis et al., 2016); he had
a proven risk factor for developing a severe form of the disease;
analysis of the relationship between comorbidities and a fatal MSF
outcome demonstrated that alcoholism is a statistically signiﬁcant
host condition which is a risk factor for a fatal outcome and for
severity of disease (De Sousa et al., 2008). Case 2 had encephalitic
symptoms but did not have risk factors like the other cases
examined. Nevertheless, most examined cases of ISF presented
severe forms of the disease and a high fatality rate was found.De Sousa et al. carried out a prospective study on 69 Portuguese
patients with ISF and compared the clinical picture and severity of
R. conorii subsp. israelensis and R. conorii subsp. conorii infection.
They showed a statistically signiﬁcantly greater severity of ISF
compared to MSF infection caused by R. conorii subsp. conorii; case
fatality rate for R. conorii subsp. israelensis was signiﬁcantly greater
than for R. conorii subsp. conorii infection (29% vs. 13%), and a
greater percentage of patients with ISF strain infection required
admission to ICU, compared to those with R. conorii subsp. conorii
infection (36% vs 22%) (De Sousa et al., 2008). All cases reported in
Israel have been fatal, as well as the two cases which occurred in
the UK – a tourist traveling in Portugal and another subject
probably infected in Libya (Weinberger et al., 2008; Znazen et al.,
2011; Boillat et al., 2008). Among the cases of ISF described in
Portugal, apart from the cases described by De Sousa, two of those
reported by Bacellar died of shock and multiorgan failure (Bacellar
et al., 1999). Of the 7 cases described in Italy, outcome was
favorable in the two cases we have reported and in two out of ﬁve
reported by Giammanco; the other 3 patients developed dissemi-
nated intravascular coagulation and progression toward coma and
one of these patients died the day after admission (Giammanco
et al., 2005a).
Therefore, R. conorii subsp. israelensis would appear to be more
virulent than R. conorii subsp. conorii even if the microbial
pathogenic mechanism by which it causes more severe illness
remains to be determined.
Gastrointestinal symptoms such as nausea, vomiting, and
diarrhea have been prominent manifestations reported in patients
with fatal course of ISF and, overall, more frequent in patients with
ISF compared with R. conorii subsp. conorii–infected patients (De
Sousa et al., 2008).
Tache noire, the black eschar at the site of the tick bite, in our
experience is present in more than 60% of cases of MSF (Cascio
et al., 2001; Colomba et al., 2006; Cascio et al., 1998; Cascio et al.,
2002); however, it is markedly less noted in ISF, where it was
present in only 27% of patients. The absence of eschar may be an
obstacle to correct diagnosis especially in cases of travelers coming
from non-endemic areas (Znazen et al., 2011; Boillat et al., 2008).
Therefore, rickettsiosis should always be suspected in febrile
travelers, especially when they present with a rash, even in the
absence of history of tick exposure and inoculation eschar; patients
should start appropriate therapy without delay if suspicion of
rickettsiosis arises in order to prevent a poor outcome due to
aggressive rickettsial strains. Indeed, the supposed ability of the ISF
rickettsia to cause life-threatening disease has been also ascribed
to late diagnosis due to its uncharacteristic presentation (Yagupsky
and Wolach, 1993).
Tetracyclines are considered standard treatment for MSF even
thought they can cause signiﬁcant adverse effects like staining of
the teeth and bone toxicity, especially in children. For this reason
the macrolides have emerged as a potential alternative therapy in
children (Cascio et al., 2001; Cascio et al., 2002; Cascio and
Colomba, 2002). In all reviewed cases, but one, doxycycline was
promptly started; delayed medical consultation and late initiation
of antimicrobial therapy (6 days after symptoms onset) may have
contributed to the fatal course in the UK tourist traveling in
Portugal (Chai et al., 2008). Haemophagocytic lymphohistiocytosis
is a rare but potentially fatal disease that can be associated with
Rickettsial infection and other zoonotic diseases (Cascio et al.,
2012; Cascio et al., 2011).
Serology was positive in only 11%. Therefore, it would be
advisable to use a PCR test that allows rapid diagnosis through the
detection of copies of rickettsial DNA (Znazen et al., 2013). Skin
biopsy specimens, particularly eschar biopsy specimens, can be
used for detection of Rickettsia spp. by molecular tools, but this
technique is invasive and painful for patients and is difﬁcult to
Table 1
Clinical characteristics, therapy and outcome of 91 ISF cases.
Author/Year
(ref)
(n. patients)
Country Age (years
or
average)
Sex Medical
history
Presenting symptoms and signs Eschar,
(n)
PCR (eschar/
blood/
autopsy)
Serology
(IFA or
ELISA)
Outcome Therapy
Fever
(n)
Cutaneous
(n)
CNS (n) Gastrointestinal (n)
Bacellar et al.
(1999) (3 pts)
Portugal 71 3 F unremarkable Yes (3) Rash (2) Headache (2) Nausea (1), Vomiting (2),
Epigastric pain (1)
Absent Blood (3 pts) Positive
(1pt)
1 Cured, 2
Died
Oral Doxycycline plus
others not speciﬁed
Amaro et al.
(2003) (8 pts)
Portugal 59.3 4M,
4 F
unremarkable Yes (8) Rash (7) Headache (5) Abdominal cramps and
pain (4), Diarrhea (2),
Vomiting (1), Upper
gastric hemorrhage (1),
Oral ulcers (1)
Present
(5 pts)
Blood (3 pts) Positive
(3 pts)
4 Cured,
4 Died
NA
Giammanco
et al. (2005a)
(5 pts)
Italy 49 3M,
2 F
unremarkable Yes (5) Rash (5) Headache (5) No Present
(2 pts)
Blood (5 pts) positive
(4 pts)
4 Cured,
1 Died
Oral Doxycycline
Weinberger
et al. (2008)
(1 pt)
Israel 51 1M unremarkable Yes Rash Headache No Absent autopsy
samples
Negative Died Oral doxycycline plus i.v.
meropenem
Chai et al.
(2008) (1 pt)
UK Traveler to
South
Portugal
63 1 F unremarkable Yes Rash Headache Diarrhea Absent autopsy
samples
Positive Died Oral doxycycline plus
ciproﬂoxacin
De Sousa et al.
(2008)
(69 pts)
Portugal NA NA unremarkable Yes (65) Rash (63) Headache (28) Vomiting (23), Diarrhea
(17)
Present
(23,
38%)
Blood and
eschar
(numbers NA)
NA 49 Cured,
20 (29%)
Died
Doxycycline (46 pt)
Doxycycline plus
ﬂuoroquinolone (7 pt)
Fluoroquinolone (6 pt)
Boillat et al.
(2008) (1 pt)
Libya 63 1M unremarkable Yes Rash Headache Epigastric pain Absent Eschar Negative Died doxycycline plus
ceftriaxone
Znazen et al.
(2011) (2 pts)
Tunisia 45, 46 2M unremarkable Yes (2) Rash (2) Headache (2) No Absent Blood (1 pt)
and eschar
(2 pts)
Positive
(1 pt)
2 Cured NA
Bota et al.
(2016) (1 pt)
Portugal 12 1 F unremarkable Yes Rash Headache Vomiting Absent Blood Positive Cured Ceftriaxone, clindamycin,
plus oral doxycycline
Present cases
(2 pts)
Italy 55 1M,
1 F
Alcoholism
(1)
Yes (2) Rash (2) Headache (2),
mental confusion
(1), dysarthria (1),
signs of meningeal
irritation (1)
Vomiting (1) Absent blood Positive
(2 pts)
2 Cured Doxycycline plus
piperacillin-tazobactam
and vancomycin
10
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detection followed by genetic characterization can determine the
genotype of the organism to the level of genus, species, and strain,
and allows an update of epidemiological knowledge. To date, the
genomes of all R. conorii subspecies have been sequenced. The
draft genome of R. conorii subsp. Israelensis yelded a total genome
of 1,252,815 nucleotides in which no plasmid has been detected.
Orthologous genes between R. conorii subsp. israelensis and the
other three R. conorii subspecies were identiﬁed suggesting that
the genomes of these bacteria were almost perfectly syntenic.
However, some genes, like those for NADH dehydrogenase I chain B
(NuoB), glycerol-3-phosphate cytidyltransferase (TagD), and
MazG-like protein were not detected in the R. conorii subsp.
israelensis genome, while they were present in those of the other
three R. conorii subspecies. Whether this difference explains the
differences in clinical expression observed among subspecies
remains to be demonstrated (Cascio et al., 2011).
In conclusion, the geographic distribution of ISF is wider than
previously thought and it is possible that severe cases of MSF
described in literature and believed to be caused by R.conori subsp.
conorii were instead caused by R. conorii subsp. israelensis
(Colomba et al., 2014; Saporito et al., 2010).
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